Factor VIII inhibitors in hemophilia A treated with emicizumab
Por um escritor misterioso
Descrição
Emicizumab for the treatment of acquired hemophilia A - ScienceDirect
ADDING MULTIMEDIA FDA Approves Genentech's HEMLIBRA (emicizumab
PDF) Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Longitudinal dynamic changes in factor VIII inhibitor titers in
Hemlibra (emicizumab-KXWH) for hemophilia
Hemlibra® (emicizumab-kxwh) for the Treatment of Haemophilia A
PDF] Laboratory monitoring of hemophilia A treatments: new
Regression Analysis to Estimate the Factor VIII Activity of
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without
Genentech's Hemlibra Approved for Hemophilia A Patients Without
Advances in the management of haemophilia: emerging treatments and
de
por adulto (o preço varia de acordo com o tamanho do grupo)